K. Rothfuss

发表

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study

A. Mebazaa, Bjoern Peters, J. Staessen, 2022, The Lancet Digital Health.

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a cohort study

J. Staessen, H. Mischak, L. Thijs, 2022, medRxiv.